Titan Pharmaceuticals, Inc.
USD2.34
-0.30 (-11.36%)
CEO
Weei Jye Chay
IPO Date
1996-01-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
KY
Open
$2.55
Prev. Close
$2.64
Day Low
$2.30
Day High
$2.69
52W Low
$2.33
52W High
$15.15
Market Cap
$0.00B
Volume
0.13M
| 5,000 |
| $0.00 |
| 28 Jan 2022 | MCNAB JAMES R | director | J-Other | Acquired | 51,021 | $50000.00 |
| 5 Jan 2022 | Rubin Marc | director, officer: Executive Chairman | A-Award | Acquired | 65,000 | $1.18 |
| 5 Jan 2022 | Akers Joseph A | director | A-Award | Acquired | 10,000 | $1.18 |
| 5 Jan 2022 | MACFARLANE M DAVID | director | A-Award | Acquired | 10,000 | $1.18 |
| 5 Jan 2022 | MCNAB JAMES R | director | A-Award | Acquired | 10,000 | $1.18 |
| 11 Feb 2021 | Rubin Marc | director, officer: Executive Chairman | A-Award | Acquired | 150,000 | $4.02 |
| 11 Feb 2021 | Akers Joseph A | director | A-Award | Acquired | 25,000 | $4.02 |
| 11 Feb 2021 | MACFARLANE M DAVID | director | A-Award | Acquired | 25,000 | $4.02 |